Clinical TrialID 5217
Combination Chemotherapy in Treating Patients With Resected Colon Cancer
NCT00378716
Colorectal Cancer
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5217
- Evidence Id
- 5217
- Core Evidence Id
- 5217
- Source Clinical Trial Id
- 5199
- Herb2 Clinical Trial Id
- HBCT005199
- Nct Id
- NCT00378716
- Title
- Combination Chemotherapy in Treating Patients With Resected Colon Cancer
- Status
- Completed
- Phase
- Phase 3
- Study Result
- No
- Study Condition
- Colorectal Cancer
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: 5-fluorouracil|DRUG: leucovorin calcium|DRUG: tegafur|DRUG: uracil
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult, Older_Adult
- Enrollment
- 1608
- Outcome Measure
- Compare the relative efficacy of UFT + LV with that of 5-FU + LV in prolonging disease-free survival and survival
- Sponsor Collaborator
- NSABP Foundation Inc|National Cancer Institute (NCI)
- Funded By
- NETWORK
- Location
- Other Id
- NSABP C-06|U10CA012027|NSABP-C-06
- Start Date
- 1997-02
- Primary Completion Date
- 2006-05
- Completion Date
- 2009-04
- First Posted
- 2006-09-21
- Results First Posted
- Last Update Posted
- 2010-01-11
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00378716
- Title Cn
- Title En
- Combination Chemotherapy in Treating Patients With Resected Colon Cancer
- Bilingual Status
- semi_complete